Abzena announces licensing agreement for T-cell engineering
Abzena has signed an antibody humanization agreement with Tmunity Therapeutics a clinical stage T cell therapy company.
Archives for September 24, 2018
CHO cells the 1900s model car in a 2020 Tesla world, says Dyadic
Dyadic’s CHO-alternative, the C1 production platform, could reduce time and cost at almost every stage of the cell development and biomanufacturing process, says CEO.